Singleron Biotechnologies
Nanjing
About Singleron Biotechnologies
Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $144.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: singleron.bio
- Phone: 025-58165529
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/singleron-biotechnologies-52592 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.